全球病理实验室市场

预计到 2030 年全球病理实验室市场规模将达到 5,648 亿美元

全球病理实验室市场规模预计在2024年达到3,747亿美元，预计2024年至2030年期间的复合年增长率为7.1%，到2030年将达到5,648亿美元。医院实验室是本报告分析的细分市场之一，预计其复合年增长率为6.7%，到分析期结束时规模将达到3,168亿美元。独立实验室细分市场在分析期间内的复合年增长率预计为8.1%。

美国市场规模估计为 1,021 亿美元，中国市场预期复合年增长率为 11.0%

美国病理实验室市场规模预计2024年达到1,021亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到1,177亿美元，在2024-2030年的分析期间内，复合年增长率为11.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.6%和6.8%。在欧洲，预计德国市场的复合年增长率为4.7%。

全球病理实验室市场—主要趋势与驱动因素摘要

病理学是现代医疗保健的支柱吗？诊断实验室的作用日益扩大

病理实验室是现代医疗保健的基石，在疾病诊断、预后和治疗计划中发挥着至关重要的作用。随着癌症、糖尿病和心血管疾病等慢性疾病负担的增加，对准确及时诊断的需求也急剧上升。病理实验室能够提供疾病病理学的关键见解，使医生能够做出明智的患者护理决策。依赖分子和基因诊断的精准医疗的兴起进一步提升了病理实验室的重要性。这些实验室不再只是进行常规血液检测的中心；它们正在整合数位病理学、人工智慧诊断工具和次世代定序(NGS) 等先进技术，以提高准确性和效率。 COVID-19 疫情凸显了病理实验室在疾病监测和疫情管理中的重要作用，进一步刺激了对诊断基础设施的投资。世界各国政府和医疗机构正在优先考虑实验室的扩建、认证和自动化，以满足日益增长的高品质诊断服务需求。随着对早期疾病检测、预防性护理和个人化治疗方法的日益重视，病理实验室正在向高通量测试和高级数据分析变革时期。

科技将如何改变病理学的未来？人工智慧、自动化和数位诊断

人工智慧 (AI)、自动化和数位病理学的融合正在改变诊断实验室的格局，使病理学服务更加准确、高效且可扩展。人工智慧驱动的影像分析工具正在增强切片检查样本的解读，从而实现更快、更准确的癌症检测。数位病理学涉及扫描数位化病理切片，有助于远距离诊断、远端病理学和人工智慧主导的评估，缩短週转时间并消除地理障碍。实验室自动化透过整合机器人样本处理、高速分析仪和云端基础资料管理系统简化工作流程，减少人为错误并提高诊断通量。机器学习演算法在病理学检测中的应用正在增强预测分析，从而实现更早的疾病检测和风险评估。分子诊断技术的进步，包括聚合酵素链锁反应(PCR) 和基因序列测定技术，正在扩展病理实验室的能力，并实现标靶治疗和个人化医疗。液态切片技术可以从血液样本中检测癌症生物标记物，它为传统切片检查提供了一种非侵入性替代方法，并正在成为病理学领域的突破性创新。随着病理实验室转向全自动、人工智慧辅助诊断模式，病理检测的未来将变得更加数据主导、高度准确和以患者为中心。

病理检测市场的关键参与者是谁？如何扩大跨部门的可近性

病理实验室市场正在各个领域显着扩张，包括医院、独立诊断连锁店、学术研究机构和政府卫生组织。医院病理实验室凭藉其内部诊断服务（支持临床和外科部门）仍然占据主导地位。 Quest Diagnostics、LabCorp 和 Eurofins 等独立诊断连锁店透过收购和合作扩大了业务范围，提供各种专科测试。家庭诊断服务日益重要，推动了直接面向消费者的病理测试需求，患者可以在线上订购测试并以数位方式获取结果。学术和研究机构正在增加对病理实验室的投资，以支持临床试验、生物标记发现和精准医疗的转化研究。世界各国政府正在扩大公共病理服务，以改善农村和服务不足地区的诊断服务。对组织病理学、细胞病理学和分子诊断等专科病理服务的需求受到癌症、感染疾病和遗传疾病日益流行的推动。此外，病理实验室正在与数位健康生态系统和电子健康记录（EMR）相结合，以增强整个医疗保健网路的诊断可访问性和数据共用。

病理实验室市场的成长受到多种因素的推动…

慢性病（尤其是癌症、心血管疾病和感染疾病）的日益普及是病理检测市场的主要驱动力。人工智慧诊断工具和数位病理解决方案的快速普及正在提高诊断准确性并减少人为错误，从而推动市场扩张。个人化医疗和精准诊断的需求日益增长，推动了对分子病理学和基因检测服务的投资。远端医疗和远距离诊断能力的兴起提高了病理服务的可及性，尤其是在农村和服务不足的地区。旨在加强医疗保健基础设施和提高诊断准确性的政府措施正在支持全球病理实验室的扩张。私人诊断连锁机构的渗透和独立实验室的整合正在创造规模经济，使诊断服务更加经济高效。对家庭检测和直接面向消费者的检测服务的需求激增，透过为消费者提供便捷快速的检测结果，正在重塑病理学市场。对早期疾病检测、预防性医疗保健和定期筛检计画的日益重视，进一步推动了病理检测服务的普及。医疗保健提供者、製药公司和诊断实验室之间的策略联盟正在促进新型生物标记和诊断检测的开发。随着医疗保健系统的不断现代化，病理检测市场正在经历强劲成长，诊断领域正在转型成为一个更以技术主导、以患者为中心的领域。

部分

类型（医院实验室、独立实验室、诊断链）、检测服务（一般生理/临床检测、影像/放射学检测、特殊检测、COVID-19 检测）、最终用途（医生转诊最终用途、无需预约最终用途、企业最终用途）

受访公司范例

• Applied BioCode
• BioReference Laboratories
• Centro de Diagnosticos Brasil
• Dr. Lal PathLabs
• Eurofins Scientific
• Exact Sciences Laboratories LLC
• Falco Holdings Co., Ltd.
• Healius Limited
• KingMed Diagnostics
• Laboratory Corporation of America Holdings（Labcorp）
• Metropolis Healthcare
• Nordic Bioscience
• PathGroup
• Quest Diagnostics Incorporated
• Roche Diagnostics
• Siemens Healthineers
• Sonic Healthcare Limited
• Spectra Laboratories
• SYNLAB International GmbH
• Unilabs

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global Pathology Laboratories Market to Reach US$564.8 Billion by 2030

The global market for Pathology Laboratories estimated at US$374.7 Billion in the year 2024, is expected to reach US$564.8 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Hospital-based Laboratories, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$316.8 Billion by the end of the analysis period. Growth in the Standalone Labs segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$102.1 Billion While China is Forecast to Grow at 11.0% CAGR

The Pathology Laboratories market in the U.S. is estimated at US$102.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$117.7 Billion by the year 2030 trailing a CAGR of 11.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Pathology Laboratories Market - Key Trends & Drivers Summarized

Is Pathology the Backbone of Modern Healthcare? The Expanding Role of Diagnostic Laboratories

Pathology laboratories serve as the cornerstone of modern healthcare, playing a pivotal role in disease diagnosis, prognosis, and treatment planning. With the increasing burden of chronic diseases such as cancer, diabetes, and cardiovascular disorders, the demand for accurate and timely diagnostics has surged. Pathology labs provide critical insights into disease pathology, allowing physicians to make informed decisions about patient care. The advent of precision medicine, which relies on molecular and genetic diagnostics, has further propelled the significance of pathology laboratories. These labs are no longer just centers for routine blood work; they now integrate sophisticated technologies such as digital pathology, AI-powered diagnostic tools, and next-generation sequencing (NGS) to enhance accuracy and efficiency. The COVID-19 pandemic highlighted the indispensable role of pathology labs in disease surveillance and outbreak management, further driving investment in diagnostic infrastructure. Governments and healthcare providers worldwide are prioritizing laboratory expansion, accreditation, and automation to meet the rising demand for high-quality diagnostic services. With an increasing emphasis on early disease detection, preventive healthcare, and personalized treatment approaches, pathology laboratories are undergoing a transformative shift towards high-throughput testing and advanced data analytics.

How Is Technology Reshaping the Future of Pathology? AI, Automation & Digital Diagnostics

The integration of artificial intelligence (AI), automation, and digital pathology is revolutionizing the landscape of diagnostic laboratories, making pathology services more accurate, efficient, and scalable. AI-powered image analysis tools are enhancing the interpretation of biopsy samples, enabling faster and more precise cancer detection. Digital pathology, which involves the scanning and digitization of pathology slides, is facilitating remote diagnostics, telepathology, and AI-driven assessments, reducing turnaround times and eliminating geographical barriers. Laboratory automation is streamlining workflows by integrating robotic sample processing, high-speed analyzers, and cloud-based data management systems, reducing human error and improving diagnostic throughput. The implementation of machine learning algorithms in pathology is enhancing predictive analytics, allowing for earlier disease detection and risk assessment. Advances in molecular diagnostics, including polymerase chain reaction (PCR) and gene sequencing technologies, are expanding the capabilities of pathology labs, enabling targeted therapies and personalized medicine. Liquid biopsy technology, which detects cancer biomarkers from blood samples, is emerging as a groundbreaking innovation in pathology, offering a non-invasive alternative to traditional biopsies. As pathology labs move towards fully automated, AI-assisted diagnostic models, the future of pathology is poised to be more data-driven, precise, and patient-centric.

Who Are the Key Players in the Pathology Market? Expanding Accessibility Across Sectors

The pathology laboratory market is witnessing significant expansion across hospitals, independent diagnostic chains, academic research institutions, and government health agencies. Hospital-based pathology labs remain dominant, as they provide in-house diagnostic services to support clinical and surgical departments. Independent diagnostic chains, such as Quest Diagnostics, LabCorp, and Eurofins, are expanding their footprint through acquisitions and partnerships, offering a wide array of specialized tests. The growing prominence of at-home diagnostic services is fueling the demand for direct-to-consumer pathology testing, where patients can order tests online and receive results digitally. Academic and research institutions are increasingly investing in pathology labs to support clinical trials, biomarker discovery, and translational research in precision medicine. Governments across various countries are expanding public pathology services to improve access to diagnostics in rural and underserved areas. The demand for specialized pathology services, such as histopathology, cytopathology, and molecular diagnostics, is rising, driven by the increasing prevalence of cancer, infectious diseases, and genetic disorders. Additionally, the integration of pathology labs with digital health ecosystems and electronic medical records (EMRs) is enhancing diagnostic accessibility and data sharing across healthcare networks.

The Growth in the Pathology Laboratories Market Is Driven by Several Factors…

The increasing prevalence of chronic diseases, particularly cancer, cardiovascular diseases, and infectious diseases, is a major driver of the pathology laboratory market. The rapid adoption of AI-powered diagnostic tools and digital pathology solutions is enhancing diagnostic accuracy and reducing human error, fueling market expansion. The growing demand for personalized medicine and precision diagnostics is driving investment in molecular pathology and genetic testing services. The rise of telemedicine and remote diagnostic capabilities is increasing accessibility to pathology services, particularly in rural and underserved regions. Government initiatives aimed at strengthening healthcare infrastructure and improving diagnostic accuracy are supporting the expansion of pathology laboratories worldwide. The increasing penetration of private diagnostic chains and the consolidation of independent laboratories are leading to economies of scale, making diagnostic services more affordable and efficient. The surge in demand for at-home and direct-to-consumer testing services is reshaping the pathology market, offering convenience and rapid test results to consumers. The growing emphasis on early disease detection, preventive healthcare, and routine screening programs is further driving the adoption of pathology services. Strategic collaborations between healthcare providers, pharmaceutical companies, and diagnostic labs are fostering the development of novel biomarkers and diagnostic tests. As healthcare systems continue to modernize, the pathology laboratory market is set for robust growth, transforming diagnostics into a more technology-driven and patient-focused domain.

SCOPE OF STUDY:

The report analyzes the Pathology Laboratories market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Hospital-based Laboratories, Standalone Labs, Diagnostic Chains); Testing Service (General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests, COVID-19 Tests); End-Use (Physician Referrals End-Use, Walk-ins End-Use, Corporate End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Applied BioCode
• BioReference Laboratories
• Centro de Diagnosticos Brasil
• Dr. Lal PathLabs
• Eurofins Scientific
• Exact Sciences Laboratories LLC
• Falco Holdings Co., Ltd.
• Healius Limited
• KingMed Diagnostics
• Laboratory Corporation of America Holdings (Labcorp)
• Metropolis Healthcare
• Nordic Bioscience
• PathGroup
• Quest Diagnostics Incorporated
• Roche Diagnostics
• Siemens Healthineers
• Sonic Healthcare Limited
• Spectra Laboratories
• SYNLAB International GmbH
• Unilabs

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Pathology Laboratories - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Chronic and Infectious Diseases Spurs Demand for Advanced Pathology Services
  • Growing Global Focus on Early Diagnosis and Preventive Care Drives Laboratory Test Volumes
  • Technological Innovation in Digital Pathology and AI-Based Image Analysis Strengthens Market Transformation
  • Increased Demand for Personalized and Precision Medicine Expands Role of Molecular Pathology Labs
  • Accelerated Adoption of Automation and Sample Throughput Optimization in Labs
  • Rising Healthcare Expenditure in Emerging Markets Propels Investment in Modern Pathology Infrastructure
  • Integration with Hospital Information Systems Enhances Workflow Efficiency and Diagnostic Turnaround
  • Laboratory Consolidation Trends Support Centralized and Scalable Testing Models
  • Surge in Cancer Screening Programs Globally Throws Spotlight on Histopathology and Cytopathology
  • Partnerships Between Diagnostics Providers and Pharma Companies Boost Companion Diagnostics Services
  • Outsourcing of Pathology Services by Hospitals Expands Market for Independent Laboratories
  • Advancements in Tissue Processing and Staining Technologies Improve Accuracy and Speed of Analysis
  • Growing Demand for Liquid Biopsy and Genomic Testing Creates New Revenue Streams for Pathology Labs
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Pathology Laboratories Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Pathology Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Pathology Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Pathology Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Hospital-based Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Hospital-based Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Hospital-based Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Standalone Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Standalone Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Standalone Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Diagnostic Chains by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Diagnostic Chains by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Diagnostic Chains by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Corporate End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Corporate End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Corporate End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Physician Referrals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Physician Referrals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Physician Referrals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Walk-ins End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Walk-ins End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Walk-ins End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for General Physiological & Clinical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for General Physiological & Clinical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for General Physiological & Clinical Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Imaging & Radiology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Imaging & Radiology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Imaging & Radiology Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Esoteric Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Esoteric Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Esoteric Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for COVID-19 Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for COVID-19 Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for COVID-19 Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• JAPAN
  • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• CHINA
  • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• EUROPE
  • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Pathology Laboratories by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Pathology Laboratories by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Pathology Laboratories by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• FRANCE
  • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• GERMANY
  • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Laboratories by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Pathology Laboratories by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Pathology Laboratories by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• INDIA
  • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Pathology Laboratories by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Pathology Laboratories by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Pathology Laboratories by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Pathology Laboratories by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Pathology Laboratories by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Pathology Laboratories by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
• AFRICA
  • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030

IV. COMPETITION